Healthcare provider profile · identity verified

Antonio Mora, M.D.

Family Practice · HIALEAH, FL · NPI 1891729919

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Losartan Potassium	Losartan Potassium	282	67
Amlodipine Besylate	Amlodipine Besylate	279	63
Rosuvastatin Calcium	Rosuvastatin Calcium	247	69
Eliquis	Apixaban	229	19
Alprazolam	Alprazolam	217	35
Levothyroxine Sodium	Levothyroxine Sodium	193	43
Atorvastatin Calcium	Atorvastatin Calcium	179	47
Temazepam	Temazepam	178	25
Gabapentin	Gabapentin	177	46
Metformin Hcl	Metformin Hcl	159	37
Carvedilol	Carvedilol	150	31
Metoprolol Succinate	Metoprolol Succinate	146	35
Omeprazole	Omeprazole	116	45
Famotidine	Famotidine	112	36
Memantine Hcl	Memantine Hcl	111	17
Tamsulosin Hcl	Tamsulosin Hcl	106	22
Vitamin D2	Ergocalciferol (Vitamin D2)	106	27
Clonazepam	Clonazepam	105	20
Hydralazine Hcl	Hydralazine Hcl	105	26
Metoprolol Tartrate	Metoprolol Tartrate	104	20
Azithromycin	Azithromycin	102	66
Furosemide	Furosemide	93	18
Clopidogrel	Clopidogrel Bisulfate	92	17
Hydrochlorothiazide	Hydrochlorothiazide	89	26
Lactulose	Lactulose	87	suppressed
Ondansetron Hcl	Ondansetron Hcl	84	14
Lisinopril	Lisinopril	81	16
Donepezil Hcl	Donepezil Hcl	79	20
Alendronate Sodium	Alendronate Sodium	69	17
Potassium Chloride	Potassium Chloride	66	suppressed
Clonidine Hcl	Clonidine Hcl	64	suppressed
Tramadol Hcl	Tramadol Hcl	64	24
Mirtazapine	Mirtazapine	61	suppressed
Folic Acid	Folic Acid	55	16
Novolin R Flexpen	Insulin Regular, Human	55	suppressed
Ibuprofen	Ibuprofen	54	26
Fluticasone Propionate	Fluticasone Propionate	53	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	51	38
Ozempic	Semaglutide	48	suppressed
Trulicity	Dulaglutide	48	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	12
Sertraline Hcl	Sertraline Hcl	44	12
Zolpidem Tartrate	Zolpidem Tartrate	44	suppressed
Mupirocin	Mupirocin	43	21
Synthroid	Levothyroxine Sodium	43	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	29
Allopurinol	Allopurinol	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	38	11
Nifedipine Er	Nifedipine	38	suppressed
Glipizide	Glipizide	37	suppressed
Januvia	Sitagliptin Phosphate	37	suppressed
Ketoconazole	Ketoconazole	37	19
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	36	12
Metformin Hcl Er	Metformin Hcl	36	suppressed
Sucralfate	Sucralfate	36	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	35	15
Ssd	Silver Sulfadiazine	35	suppressed
Trazodone Hcl	Trazodone Hcl	34	11
Carbidopa-Levodopa	Carbidopa/Levodopa	33	suppressed
Novolog Flexpen	Insulin Aspart	33	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Sildenafil Citrate	Sildenafil Citrate	31	suppressed
Gemtesa	Vibegron	30	suppressed
Methylprednisolone	Methylprednisolone	30	26
Buspirone Hcl	Buspirone Hcl	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	28	11
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Diclofenac Sodium Er	Diclofenac Sodium	28	suppressed
Diltiazem Hcl	Diltiazem Hcl	27	suppressed
Entresto	Sacubitril/Valsartan	27	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	27	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Megestrol Acetate	Megestrol Acetate	26	12
Meloxicam	Meloxicam	26	suppressed
Montelukast Sodium	Montelukast Sodium	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Finasteride	Finasteride	22	suppressed
Risedronate Sodium	Risedronate Sodium	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Linzess	Linaclotide	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Baclofen	Baclofen	18	14
Cefuroxime	Cefuroxime Axetil	18	13
Digoxin	Digoxin	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Benicar	Olmesartan Medoxomil	16	suppressed
Brilinta	Ticagrelor	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Ertapenem	Ertapenem Sodium	16	suppressed
Fluconazole	Fluconazole	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Levofloxacin	Levofloxacin	16	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	11
Atenolol	Atenolol	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	15	suppressed
Celecoxib	Celecoxib	14	suppressed
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Meropenem	Meropenem	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Oxcarbazepine	Oxcarbazepine	13	suppressed
Prednisone	Prednisone	13	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Novolin R	Insulin Regular, Human	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Calcitriol	Calcitriol	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Methimazole	Methimazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nystatin	Nystatin	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error